Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects
Adetola L Shodeinde,1 Beverly E Barton21Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA; 2Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USAAbs...
Main Authors: | Shodeinde AL, Barton BE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-07-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/potential-use-of-stat3-inhibitors-in-targeted-prostate-cancer-therapy--a10304 |
Similar Items
-
STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects
by: Milad Ashrafizadeh, et al.
Published: (2020-06-01) -
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.
by: Holger H H Erb, et al.
Published: (2020-01-01) -
Synthesis of angucycline-based small molecules as potential STAT3 : STAT3 protein-protein interaction inhibitors for cancer therapy
by: Misale, Antonio
Published: (2012) -
Targeting STAT3 and STAT5 in Cancer
by: Elvin D. de Araujo, et al.
Published: (2020-07-01) -
Targeting STAT3 and STAT5 in Cancer
Published: (2020)